Quarterly report pursuant to Section 13 or 15(d)

Unaudited Consolidated Statements of Cash Flow

v3.21.2
Unaudited Consolidated Statements of Cash Flow - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash provided by (used for): Operating activities    
Net income (loss) for the year $ (23,754,000) $ (9,564,000)
Items not affecting cash:    
Stock based compensation 779,000 693,000
Net realizable value adjustments 5,211,000 6,296,000
Amortization of mineral properties 1,525,000 1,850,000
Depreciation of capital assets 1,336,000 1,365,000
Accretion expense 365,000 433,000
Amortization of deferred loan costs 32,000 58,000
Gain on loan forgiveness (900,000) 0
Provision for reclamation 0 18,000
Mark to market loss (gain) 11,384,000 (592,000)
Gain on sale of assets 0 (16,000)
Unrealized foreign exchange loss (gain) 350,000 0
Accounts receivable (15,000) 8,000
Inventory (5,318,000) (6,489,000)
Prepaid expenses (381,000) (58,000)
Accounts payable and accrued liabilities 253,000 154,000
Net cash used in Operating activites (9,133,000) (5,844,000)
Investing activities    
Proceeds from sale of capital assets 0 18,000
Purchase of capital assets (63,000) (38,000)
Net cash in Investing activites (63,000) (20,000)
Financing activities    
Issuance of common shares and warrants for cash 32,280,000 4,680,000
Share issue costs (1,778,000) (429,000)
RSU redeemed for cash 0 (45,000)
Proceeds from exercise of warrants and stock options 7,822,000 0
Proceeds from debt financing 0 893,000
Net cash in Financing activites 38,324,000 5,099,000
Effects of foreign exchange rate changes on cash 19,000 50,000
Increase (decrease) in cash, cash equivalents, and restricted cash 29,147,000 (715,000)
Beginning cash, cash equivalents, and restricted cash 12,127,000 15,215,000
Ending cash, cash equivalents, and restricted cash $ 41,274,000 $ 14,500,000